A61P 15 - Drugs for genital or sexual disorders; Contraceptives

Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
10/2002
10/31/2002	US20020161036 Chalcone coumarins
10/31/2002	US20020161033 Substituted 1,5-dihydropyrrol-2-one derivatives active as NMDA receptor antagonists for treatment of states of pain
10/31/2002	US20020161017 For amelioration of erectile dysfunction in a mammal without causing substantial intolerable adverse side effects to mammal
10/31/2002	US20020161016 As-needed administration of tricyclic and other non-SRI antidepressant drugs to treat premature ejaculation
10/31/2002	US20020161009 Use of selective antagonists of the alpha1b-adrenergic receptor for improvement of sexual dysfunction
10/31/2002	US20020160999 Treatment of diseases or disorders of the central nervous system
10/31/2002	US20020160997 Novel indole derivatives
10/31/2002	US20020160951 Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
10/31/2002	US20020160487 Testis specific transcription factor ZGCL-1
10/31/2002	US20020160059 Treatment of urogenital disorders, menstrual cramps
10/31/2002	US20020160000 PD-1, a receptor for B7-4, and uses therefor
10/31/2002	DE10121217A1 6H-Oxazolo[4,5-e]indol-Derivate als nikotinische Acetylcholinrezeptor Liganden und/oder serotonerge Liganden 6H-oxazolo [4,5-e] indole derivatives as nicotinic acetylcholine receptor ligands and / or serotonergic ligands
10/31/2002	DE10121215A1 Dihydro-imidazo[4,5-e]indol- und 7H-Pyrrolo[3,2-f]chinoxalin Derivate als nikotinische Acetylcholinrezeptor Liganden und/oder serotonerge Liganden Dihydro-imidazo [4,5-e] indole and 7H-pyrrolo [3,2-f] quinoxaline derivatives as nicotinic acetylcholine receptor ligands and / or serotonergic ligands
10/31/2002	CA2445740A1 Use of metals to treat inflammatory skin conditions
10/31/2002	CA2445734A1 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use to induce apoptosis in cancerous tissue
10/31/2002	CA2445729A1 Use of metals to treat mucosal membranes
10/31/2002	CA2445233A1 Phthalazinones derivatives useful as pde4/7 inhibitors
10/31/2002	CA2445188A1 Arylindenopyridines with pde inhibiting activity
10/31/2002	CA2445087A1 Hop extracts and use thereof in the production of a medicament having estrogenic properties
10/31/2002	CA2444599A1 Melanocortin receptor ligands
10/31/2002	CA2444235A1 New polynucleotides and polypeptides of the ifn.alpha.-17 gene
10/31/2002	CA2443587A1 Therapeutic treatments using the direct application of antimicrobial metal compositions
10/31/2002	CA2443556A1 Novel 3-c(o)r substituted 10-cyclohexylbenzoyl pyrrolobenzodiazepines; tocolytic oxytocin receptor antagonists
10/31/2002	CA2443373A1 New polynucleotides and polypeptides of the erythropoietin gene
10/30/2002	EP1253396A1 Automatic grenade launcher
10/30/2002	EP1252165A1 Isoxazolo pyrimidinones and the use thereof
10/30/2002	EP1252153A1 Substituted piperidines, medicaments containing these compounds, and methods for the production thereof
10/30/2002	EP1252150A1 Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same
10/30/2002	EP1252143A1 Method for preparing alpha-sulfonyl hydroxamic acid derivatives
10/30/2002	EP1251864A1 Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release
10/30/2002	EP1251739A2 Poly(dipeptide) as a drug carrier
10/30/2002	CN1377424A Methods of reparing tandemly repeated DNA sequences and extending cell life-span using nuclear transfer
10/30/2002	CN1377357A Pyrazolo [4,3-d] pyrimidines
10/30/2002	CN1377356A Certain alkylene diamine-substituted heterocycles
10/30/2002	CN1377355A Amino substituted pyrazolo [1,5-2]-1,5-pyrimidines and pyrazolo [1,5-2]-1,3, 5-triazines
10/30/2002	CN1377354A Certain alkylene diamine-substituted pyrazolo [1,5-a]-1,5-pyrimidines and pyrazolo [1,5-a]-1,3,5-triazines
10/30/2002	CN1377352A Selective antagonists of A28 adenosine receptors
10/30/2002	CN1377346A Z-pyrazoline-5-ones
10/30/2002	CN1377279A Use of soluble cosmetimulatory molecules to enhance immune responses
10/30/2002	CN1377277A Use of leptin in inhibition of endothelial cell proliferation
10/30/2002	CN1377274A Treatment of chronic viral infections with i (M. Vannae)
10/30/2002	CN1377271A Use of thienopyrimidines
10/30/2002	CN1377270A B-carboline drug products
10/30/2002	CN1377264A Method for treating endometriosis or infertility, or improving fertility
10/30/2002	CN1376504A Intravenous injection of Chinese angelica root and its preparing process
10/30/2002	CN1376488A Ointment for treating cracked nipple
10/30/2002	CN1376481A Liquid medicine 'Baoan Cuisheng' for helping childbirth
10/30/2002	CN1093404C Medicine for treating breast addiction and its preparing process
10/29/2002	US6472531 Single reaction vessel acylation and deetherification production of crystalline, high purity chemical intermediates for such as pharmaceuticals
10/29/2002	US6472434 Vasoactive agent is administered to the vagina, vulvar area or urethra of the individual undergoing treatment. suitable vasoactive agents are vasodilators, including naturally occurring prostaglandins, synthetic prostaglandin derivatives,
10/29/2002	US6472418 Non-peptide NK1 receptors antagonists
10/29/2002	US6472398 Spiropiperidine derivatives as melanocortin receptor agonists
10/29/2002	US6472379 Angiogenesis inhibition
10/29/2002	US6472374 Endometrial function
10/29/2002	US6472367 Compounds and methods for modulating OB-cadherin mediated cell adhesion
10/29/2002	US6471959 Human transferase
10/29/2002	CA2156493C Method of preventing or inhibiting fertilization
10/25/2002	CA2383175A1 Methods and kits for treating depression or preventing deterioration of cognitive function
10/24/2002	WO2002083950A1 Methods and compositions for treating cardiovascular disease using 10218
10/24/2002	WO2002083873A2 Enzymes
10/24/2002	WO2002083870A2 Pufa polyketide synthase systems and uses thereof
10/24/2002	WO2002083736A2 G-protein coupled receptor molecules and uses thereof
10/24/2002	WO2002083704A1 Vascular endothelial growth factor 2
10/24/2002	WO2002083684A1 Novel pyridine- and cyclohexenyl-comprising pyrrolobenzodiazepi ne-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists
10/24/2002	WO2002083683A1 Novel tricyclic pyridyl benzazepine carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
10/24/2002	WO2002083682A1 Novel 10-cyclohexenyl-phenyl pyrrolobenzodiazepine-3-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists
10/24/2002	WO2002083681A1 Novel cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
10/24/2002	WO2002083680A1 Novel tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
10/24/2002	WO2002083679A1 Novel hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
10/24/2002	WO2002083678A1 Tricyclic diazepines as tocolytic oxytocin receptor antagonists
10/24/2002	WO2002083674A2 Compositions containing imidazotriazinone for nasal application
10/24/2002	WO2002083666A1 Substituted benzofuran-2-carboxamides derivatives
10/24/2002	WO2002083643A1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
10/24/2002	WO2002083627A2 Ligands des integrins avss6
10/24/2002	WO2002083241A1 Single dose aromatase inhibitor for treating infertility
10/24/2002	WO2002083240A1 Aromatase inhibition to enhance assisted reproduction
10/24/2002	WO2002083239A1 Aromatase inhibitors for treating infertility
10/24/2002	WO2002083152A1 Activation of natural killer cells by adenosine a3 receptor agonists
10/24/2002	WO2002083146A1 Multiple dose aromatase inhibitor for treating infertility
10/24/2002	WO2002083128A1 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase iv and method
10/24/2002	WO2002083108A2 Compositions containing cgmp pde inhibitors and local anaesthetic agents for nasal application
10/24/2002	WO2002083104A1 An effervescent solid composition of matter
10/24/2002	WO2002083072A2 Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives
10/24/2002	WO2002053140A3 New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents
10/24/2002	WO2002051848A3 Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors
10/24/2002	WO2002050065A3 Pyrazole compounds useful as protein kinase inhibitors
10/24/2002	WO2001076568B1 Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
10/24/2002	WO2001068676A3 Lhrh-antagonists, production and use thereof as medicament
10/24/2002	WO2001055337A3 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides
10/24/2002	US20020156264 And method of using the carboxypeptidase polypeptides and polynucleotides as a target for diagnosis and treatment in carboxypeptidase-related disorders
10/24/2002	US20020156090 Estrogen agonist/antagonist to prevente myocardial infarction or stroke, maintaining or improving vascular reactivity, treat renal failure, peripheral arterial occlusive disease, coronary artery disease, or raynaud's phenomenon
10/24/2002	US20020156081 Pyrazolopyrimidines as therapeutic agents
10/24/2002	US20020156067 New drug combinations
10/24/2002	US20020156059 Selective estrogen replacement therapy to treat menpausal symptoms
10/24/2002	US20020156056 Fast-dispersing dosage form of apomorphine and testosterone that disintegrates in the oral cavity within 1-30 seconds
10/24/2002	US20020156055 Method of regulating the female reproductive system through angiogenesis inhibitors
10/24/2002	US20020156027 Ketolide antibiotics
10/24/2002	US20020155992 Paclitaxel, epipodophyllotoxin, decetaxel, topotecan, and podophyllotoxin covalently conjugated to a polypeptide drug carrier having 50-90% by weight glutamic acid; inproved solubility
10/24/2002	US20020155136 Using in combination, of yohimbine and arginine as active ingredients in the preparation of a medicinal product intended for treating erectile dysfunction
10/24/2002	US20020155115 Cancer therapy

1 ... 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 ... 557